Elixir Medical Bioabsorbable Polymer Drug-Eluting Stents Featured at TCT 2009

September 17, 2009 – Elixir Medical Corp. said today its stent systems using bioabsorbable polymers will be featured in multiple sessions at the 21st annual Transcatheter Cardiovascular Therapeutics scientific symposium (TCT 2009), Sept. 21-25, in San Francisco.

Clinical results from the company’s Novolimus and Myolimus eluting stent systems with durable and bioabsorbable polymers will be discussed in the following sessions:

• “Single center, first-in-man study of the Elixir novolimus-eluting coronary stent system with durable polymer: 24-month clinical safety and efficacy results,” Alexandre Abizaid, M.D., Ph.D. 8-10 a.m., Poster Session Hall D, Tuesday, Sept. 22.

• “The Elixir Bioabsorbable Polymer Myolimus-Eluting Stent Program,” Lecturer: Bernhard Witzenbichler, M.D., 2:16 p.m., DES Summit, room 104, Tuesday, Sept. 22.

• “The Elixir Bioabsorbable Polymer Novolimus-Eluting Stent Program,” Lecturer: Alexandre Abizaid, M.D., Ph.D., 2:23 p.m., DES Summit, room 104, Tuesday, Sept. 22.

For more information: www.elixirmedical.com